The Miller School of Medicine’s Bascom Palmer Eye Institute was rated the nation’s #1 ophthalmology program for the 18th consecutive year in US News’s annual 2019 Best Hospitals rankings from US News & World Report.
The Active Times ranked the University of Miami No. 41 on its list of the 50 Fittest Colleges, schools that emphasize on keeping students active, promote athletics, and provide healthy dining options.
Bringing Florida into the NIH-funded Women’s Interagency HIV Study, Miller School of Medicine HIV/AIDS researchers in February 2013 are awarded $8.5 million over five years to provide clinical, behavioral, and basic science insights into the changing demographics of the HIV epidemic among women in the United States.
In December 2012, doctors at The Miami Project to Cure Paralysis perform the first-ever FDA-approved Schwann cell transplantation in a patient with a new spinal cord injury.
A record nine students from five UM schools and colleges received Fulbright scholarships to conduct research and teach during the 2013-2014 academic year in eight different countries: Ecuador, Germany, Mexico, Malaysia, Poland, Sweden, Tanzania, and Wales..
Leading the University of Miami into the next frontier of education, the Miller School of Medicine’s Department of Biochemistry and Molecular Biology has established a unique degree program that will enable industry and government scientists to remain on the job—and in their labs—while earning a Doctor of Philosophy in Industrial Biochemistry and Molecular Biology.
Mary Bartlett Bunge, professor of cell biology, neurological surgery, and neurology at the Miller School of Medicine’s Miami Project to Cure Paralysis, was elected to the National Academy of Sciences Institute of Medicine. In another remarkable achievement, Bunge also received a five-year renewal of NIH funding for her 39-year-old individual research grant.